SPADEL SA (SPA.BR) Stock Fundamental Analysis
EBR:SPA - BE0003798155 - Common Stock
220 EUR
+2 (+0.92%)
SPA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 24 industry peers in the Beverages industry. Both the health and profitability get an excellent rating, making SPA a very profitable company, without any liquidiy or solvency issues. SPA is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year SPA was profitable.
In the past year SPA had a positive cash flow from operations.
Each year in the past 5 years SPA has been profitable.
SPA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of SPA (8.71%) is better than 91.67% of its industry peers.
Looking at the Return On Equity, with a value of 13.22%, SPA is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
With an excellent Return On Invested Capital value of 11.50%, SPA belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
SPA had an Average Return On Invested Capital over the past 3 years of 8.57%. This is in line with the industry average of 7.87%.
The 3 year average ROIC (8.57%) for SPA is below the current ROIC(11.50%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.71% | ||
| ROE | 13.22% | ||
| ROIC | 11.5% |
ROA(3y)6.19%
ROA(5y)6.45%
ROE(3y)9.43%
ROE(5y)10.16%
ROIC(3y)8.57%
ROIC(5y)9.02%
1.3 Margins
SPA has a better Profit Margin (10.82%) than 70.83% of its industry peers.
In the last couple of years the Profit Margin of SPA has grown nicely.
SPA's Operating Margin of 12.85% is in line compared to the rest of the industry. SPA outperforms 41.67% of its industry peers.
SPA's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 39.41%, SPA is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of SPA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.85% | ||
| PM (TTM) | 10.82% | ||
| GM | 39.41% |
OM growth 3Y-0.5%
OM growth 5Y1.58%
PM growth 3Y4.62%
PM growth 5Y3.65%
GM growth 3Y1.4%
GM growth 5Y1.36%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SPA is creating some value.
SPA has about the same amout of shares outstanding than it did 1 year ago.
SPA has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for SPA is higher compared to a year ago.
2.2 Solvency
SPA has an Altman-Z score of 5.74. This indicates that SPA is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.74, SPA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Debt to FCF ratio of SPA is 0.12, which is an excellent value as it means it would take SPA, only 0.12 years of fcf income to pay off all of its debts.
SPA has a Debt to FCF ratio of 0.12. This is amongst the best in the industry. SPA outperforms 100.00% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that SPA is not too dependend on debt financing.
SPA has a better Debt to Equity ratio (0.01) than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.12 | ||
| Altman-Z | 5.74 |
ROIC/WACC1.46
WACC7.88%
2.3 Liquidity
SPA has a Current Ratio of 1.82. This is a normal value and indicates that SPA is financially healthy and should not expect problems in meeting its short term obligations.
SPA has a Current ratio of 1.82. This is in the better half of the industry: SPA outperforms 66.67% of its industry peers.
A Quick Ratio of 1.63 indicates that SPA should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.63, SPA belongs to the top of the industry, outperforming 95.83% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.63 |
3. Growth
3.1 Past
SPA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.32%, which is quite impressive.
The Earnings Per Share has been growing by 8.75% on average over the past years. This is quite good.
Looking at the last year, SPA shows a quite strong growth in Revenue. The Revenue has grown by 9.66% in the last year.
SPA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.92% yearly.
EPS 1Y (TTM)45.32%
EPS 3Y15.47%
EPS 5Y8.75%
EPS Q2Q%64.21%
Revenue 1Y (TTM)9.66%
Revenue growth 3Y10.37%
Revenue growth 5Y4.92%
Sales Q2Q%12.07%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 22.24 indicates a rather expensive valuation of SPA.
The rest of the industry has a similar Price/Earnings ratio as SPA.
The average S&P500 Price/Earnings ratio is at 27.07. SPA is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.24 | ||
| Fwd PE | N/A |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as SPA.
SPA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SPA is cheaper than 62.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.27 | ||
| EV/EBITDA | 10.82 |
4.3 Compensation for Growth
The decent profitability rating of SPA may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.54
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
SPA has a Yearly Dividend Yield of 1.06%. Purely for dividend investing, there may be better candidates out there.
With a Dividend Yield of 1.06, SPA pays less dividend than the industry average, which is at 2.88. 87.50% of the companies listed in the same industry pay a better dividend than SPA!
With a Dividend Yield of 1.06, SPA pays less dividend than the S&P500 average, which is at 2.46.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.06% |
5.2 History
The dividend of SPA has a limited annual growth rate of 1.92%.
Dividend Growth(5Y)1.92%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
SPA pays out 22.25% of its income as dividend. This is a sustainable payout ratio.
SPA's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP22.25%
EPS Next 2YN/A
EPS Next 3YN/A
EBR:SPA (9/9/2025, 7:00:00 PM)
220
+2 (+0.92%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners97.59%
Ins Owner ChangeN/A
Market Cap913.00M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.06% |
Yearly Dividend2.2
Dividend Growth(5Y)1.92%
DP22.25%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.24 | ||
| Fwd PE | N/A | ||
| P/S | 2.41 | ||
| P/FCF | 20.27 | ||
| P/OCF | 13.32 | ||
| P/B | 2.94 | ||
| P/tB | 4.59 | ||
| EV/EBITDA | 10.82 |
EPS(TTM)9.89
EY4.5%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)10.85
FCFY4.93%
OCF(TTM)16.51
OCFY7.51%
SpS91.41
BVpS74.79
TBVpS47.88
PEG (NY)N/A
PEG (5Y)2.54
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.71% | ||
| ROE | 13.22% | ||
| ROCE | 14.26% | ||
| ROIC | 11.5% | ||
| ROICexc | 20.47% | ||
| ROICexgc | 48.93% | ||
| OM | 12.85% | ||
| PM (TTM) | 10.82% | ||
| GM | 39.41% | ||
| FCFM | 11.87% |
ROA(3y)6.19%
ROA(5y)6.45%
ROE(3y)9.43%
ROE(5y)10.16%
ROIC(3y)8.57%
ROIC(5y)9.02%
ROICexc(3y)13.94%
ROICexc(5y)13.81%
ROICexgc(3y)32.94%
ROICexgc(5y)32.52%
ROCE(3y)10.63%
ROCE(5y)11.39%
ROICexcg growth 3Y14.92%
ROICexcg growth 5Y8.53%
ROICexc growth 3Y13.66%
ROICexc growth 5Y8.37%
OM growth 3Y-0.5%
OM growth 5Y1.58%
PM growth 3Y4.62%
PM growth 5Y3.65%
GM growth 3Y1.4%
GM growth 5Y1.36%
F-Score6
Asset Turnover0.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.12 | ||
| Debt/EBITDA | 0.05 | ||
| Cap/Depr | 105.67% | ||
| Cap/Sales | 6.19% | ||
| Interest Coverage | 66.51 | ||
| Cash Conversion | 96.54% | ||
| Profit Quality | 109.76% | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.63 | ||
| Altman-Z | 5.74 |
F-Score6
WACC7.88%
ROIC/WACC1.46
Cap/Depr(3y)93.53%
Cap/Depr(5y)93.22%
Cap/Sales(3y)5.83%
Cap/Sales(5y)6.29%
Profit Quality(3y)136.29%
Profit Quality(5y)124.06%
High Growth Momentum
Growth
EPS 1Y (TTM)45.32%
EPS 3Y15.47%
EPS 5Y8.75%
EPS Q2Q%64.21%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.66%
Revenue growth 3Y10.37%
Revenue growth 5Y4.92%
Sales Q2Q%12.07%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y42.35%
EBIT growth 3Y9.82%
EBIT growth 5Y6.57%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y12.06%
FCF growth 3Y16.51%
FCF growth 5Y18.57%
OCF growth 1Y10.87%
OCF growth 3Y13.89%
OCF growth 5Y11.4%